1. Home
  2. ORIS vs CNSP Comparison

ORIS vs CNSP Comparison

Compare ORIS & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ORIS

Oriental Rise Holdings Limited Ordinary Shares

HOLD

Current Price

$1.52

Market Cap

3.7M

ML Signal

HOLD

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

HOLD

Current Price

$5.23

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORIS
CNSP
Founded
2014
2017
Country
China
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
3.8M
IPO Year
2024
2019

Fundamental Metrics

Financial Performance
Metric
ORIS
CNSP
Price
$1.52
$5.23
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$20.00
AVG Volume (30 Days)
180.5K
20.8K
Earning Date
04-30-2026
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$12,317,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$163.69
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.14
$4.93
52 Week High
$57.00
$114.00

Technical Indicators

Market Signals
Indicator
ORIS
CNSP
Relative Strength Index (RSI) 96.29 30.95
Support Level $0.06 $6.00
Resistance Level $0.11 $6.17
Average True Range (ATR) 0.05 0.61
MACD 0.13 -0.17
Stochastic Oscillator 85.91 1.08

Price Performance

Historical Comparison
ORIS
CNSP

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: